November/December 2002
Meet the Chief Medical Editors
Endovascular Today is proud to have three of the nation’s top endovascular specialists as our Chief Medical Editors. To ensure that our focus encompasses all specialists who participate in endovascular therapies, we have chosen Chief Medical Editors from the fields of interventional cardiology, interventional radiology, and vascular surgery.
Chief Medical Editor's Page
Endovascular Treatment of AAAs
Letters
The Lower Extremity Grading System
An objective scoring method may help interventionalists select the optimal treatment for patients with peripheral arterial disease.
Renal Artery Stenosis and Renal Insufficiency
Weigh individual risks and benefits to determine whether revascularization will improve kidney function.
Uterine Fibroid Embolization
Successful patient selection is difficult, but it makes all the difference.
Acute MI Intervention
Distal protection improves the outcome of coronary intervention.
Challenging Case
Intermittent Claudication of the Jaw
Patient Selection for Endovascular AAA Repair
Interventionalists should strive to balance physiologic and anatomic risk factors.
Preprocedural Imaging
Formulate your best endograft plan with a combination of preprocedure imaging and postimaging processing.
Which Endograft Is Best?
Personal recommendations for achieving the best AAA outcome.
Endoleak Following AAA Repair
Problems detected during follow-up affect treatment durability and success.
AAA Endografting in the Cath Lab
The requirements for this procedure remain the same wherever it is performed.
Late Endograft Failure
Improvements in preclinical testing will help reduce the risk of failure.
Open Surgical Repair
Some AAA patients simply fare better with surgery.
Protecting Your Assets From Malpractice Claims
Three mechanisms can prevent malpractice creditors from seizing your assets.
FDA Advisory Panels
What exactly are you up againstand why?
Innovations
A preview of today’s new products
Five Questions
A true pioneer, Dr. Juan Carlos Parodi surmounted adversity to develop revolutionary aneurysm endograft technology.
|